<SEC-DOCUMENT>0001140361-19-013125.txt : 20190718
<SEC-HEADER>0001140361-19-013125.hdr.sgml : 20190718
<ACCEPTANCE-DATETIME>20190718161253
ACCESSION NUMBER:		0001140361-19-013125
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20190718
FILED AS OF DATE:		20190718
DATE AS OF CHANGE:		20190718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			InflaRx N.V.
		CENTRAL INDEX KEY:			0001708688
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38283
		FILM NUMBER:		19961440

	BUSINESS ADDRESS:	
		STREET 1:		WINZERLAER STR. 2
		CITY:			JENA
		STATE:			2M
		ZIP:			07745
		BUSINESS PHONE:		49 3641 508180

	MAIL ADDRESS:	
		STREET 1:		WINZERLAER STR. 2
		CITY:			JENA
		STATE:			2M
		ZIP:			07745

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Fireman B.V.
		DATE OF NAME CHANGE:	20170606
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 6.1.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
  <div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 25%; color: #000000;"></div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 6-K</div>
    <div style="font-weight: 400;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 25%; color: #000000;"></div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 or 15d-16 of</div>
    <div style="text-align: center; font-weight: bold;">the Securities Exchange Act of 1934</div>
    <div><br>
    </div>
    <div style="text-align: center;">July, 2019</div>
    <div><br>
    </div>
    <div style="text-align: center;">Commission File Number: 001-38283</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 25%; color: #000000;"></div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 24pt; font-weight: bold;">InflaRx N.V.</div>
    <div style="font-weight: 400;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 25%; color: #000000;"></div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Winzerlaer Str. 2</div>
    <div style="text-align: center; font-weight: bold;">07745 Jena, Germany</div>
    <div style="text-align: center; font-weight: bold;">(+49) 3641 508180</div>
    <div style="text-align: center;">(Address of principal executive offices)</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 25%; color: #000000;"></div>
    <div><br>
    </div>
    <div>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 2.7pt;">Form 20-F &#9746; Form 40-F &#9744;</div>
    <div><br>
    </div>
    <div>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</div>
    <div><br>
    </div>
    <div>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</div>
    <div> <br>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div></div>
    <div style="text-align: justify;">
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">INFLARX N.V.</div>
      <div>&#160;</div>
      <div>On July 18, 2019, InflaRx N.V. issued a press release titled &#8220;InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa.&#8221;</div>
      <div>&#160;</div>
      <div>A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%3%%%-->
      <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
      <div>&#160;</div>
      <div style="text-align: left; text-indent: 15.15pt; margin-right: 18.05pt; margin-left: 6pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned, thereunto duly authorized, in the City of Jena, Germany, July 18, 2019.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc72ba043189840f09225889a275a0e50">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="3" rowspan="1" style="vertical-align: top;">
              <div>INFLARX N.V.</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="3" rowspan="1" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 7%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td colspan="2" style="vertical-align: top; border-bottom: 2px solid black;">
              <div>/s/ Niels Riedemann</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 7%; vertical-align: top;"><br>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div>
                <div>Name:</div>
              </div>
            </td>
            <td style="width: 37%; vertical-align: top;">Niels Riedemann</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 7%; vertical-align: top;"><br>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div>
                <div>Title:</div>
              </div>
            </td>
            <td style="width: 37%; vertical-align: top;">Chief Executive Officer</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">EXHIBIT INDEX</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb4d9e11720db404993976abc354cecdd">

          <tr>
            <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="font-weight: bold;">Exhibit</div>
              </div>
            </td>
            <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="font-weight: bold;">Description of Exhibit</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: bottom;">
              <div><a href="ex99_1.htm">99.1</a></div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 88%; vertical-align: bottom;">
              <div>Press release dated July 18, 2019</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font> </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 6.1.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="font-weight: bold; text-align: right;">Exhibit 99.1<br>
      </div>
      <div style="font-weight: bold; text-align: right;"> <br>
      </div>
      <div style="font-weight: bold;"><img src="image00006.jpg"> </div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt;">InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa</div>
      <div><br>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5a6c3ec7c40647709c60787e63c29411">

              <tr>
                <td style="width: 42.55pt;"><br>
                </td>
                <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>IFX-1 treatment in high dose group resulted in multiple efficacy signals supporting further development of IFX-1 in HS</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
        </div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7c2b523aefc64427acb6e454f857c729">

              <tr>
                <td style="width: 42.55pt;"><br>
                </td>
                <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>IFX-1 suppressed C5a levels dose dependently and exhibited a favorable safety profile with low anti-drug antibody rates</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
        </div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa46caecae794fea96272ccd0070d627">

              <tr>
                <td style="width: 42.55pt;"><br>
                </td>
                <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Open-label extension study is ongoing, InflaRx plans end of Phase II regulatory discussions after completion of SHINE trial</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
        </div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b9840f7b2d444fc9ae01b09094948b0">

              <tr>
                <td style="width: 42.55pt;"><br>
                </td>
                <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Conference call on July 19, 2019 at 8 am EDT, 2 pm CEST</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold;">Jena, Germany, July 18, 2019 </font>&#8211; InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,
        today reported additional in-depth analysis of the completed double blind, placebo controlled part of the ongoing international SHINE Phase IIb study to supplement InflaRx&#8217;s top line disclosure of results reported on June 5, 2019. The purpose of
        this study is to investigate the safety and efficacy of IFX-1, a first-in-class anti-human complement factor C5a monoclonal antibody, in patients suffering from moderate to severe Hidradenitis Suppurativa (HS), a painful and debilitating chronic
        inflammatory skin disease with limited treatment options.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Prof. Niels C. Riedemann, CEO and Founder of InflaRx, commented: &#8220;While we were very disappointed about missing our primary endpoint in the SHINE study, our in depth post-hoc data analysis suggests a robust
        anti-inflammatory activity in the high dose IFX-1 treatment group across numerous efficacy measures which were not reflected by the HiSCR. The company has made significant efforts to research the available data set and has engaged with US and
        European experts to assist in the analysis and interpretation of these findings. Based on this, our team continues to work on the development of IFX-1 in HS. We look forward to discussions with the regulatory authorities upon completion of the open
        label extension portion of the ongoing SHINE study&#8221;, he added.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">The randomized, double-blind, placebo-controlled, multicenter study, which enrolled a total of 179 patients in four active dose arms and a placebo arm at over 40 sites in North America and Europe, recently reported a
        failure to achieve its primary endpoint, a dose dependent drug effect on Hidradenitis Suppurativa Clinical Response Score (HiSCR). In order to be a responder in this binary score, the total body count of abscesses and inflammatory nodules (AN
        count) must be reduced by at least 50% while the abscesses and draining fistula count may not accede baseline counts. The score thus does not account for any reduction in draining fistulas. The placebo arm demonstrated an unusually high HiSCR
        response rate at week 16 of 47.2%, when compared to earlier reported larger studies (Pioneer 1: 26% / Pioneer 2: 27.6%, both at week 12). An in-depth patient by patient data analysis revealed a very high variability of the HiSCR responses in all
        trial groups, which was strongly affected by a large individual fluctuation of the AN count.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="z4f9c49df35594ad9b14b4df484406811" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; font-size: 8pt; text-align: right;"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">1</font>/7<br>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="ze30f47c0d8424f9e99e816be33df576a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100.00%;">
                  <div style="text-align: justify;">
                    <div style="font-weight: bold; text-align: left;"><img src="image00006.jpg"> </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;">The inclusion and exclusion criteria of the SHINE study were nearly identical to the ones used in an earlier published trial, the PIONEER II study, and the baseline characteristics of the placebo group in the SHINE
        study were comparable to those of the PIONEER II study with a good distribution across all dose groups. This accounts especially for the median AN count, median draining fistula count, gender distribution, Hurley Stage II and III distribution and
        others. Despite various additional efforts including post-hoc sensitivity analysis on parameters like differences in HiSCR responder rates in patients with low or high AN count at baseline, in Hurley II versus III patients, in severe versus
        moderately diseased patients, as well as clinical trial-site analysis, and several others, the profound difference in the HiSCR response rates between these two trials could not be explained by the results of these analyses. Importantly, no
        underlying trial conduct problem to account for the high placebo HiSCR rate could be detected.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">InflaRx conducted an in-depth efficacy analysis (secondary endpoints as well as additional post-hoc analysis) upon receipt of the full data set of the first 16 weeks of the SHINE study and, consecutively, consulted
        with key opinion leaders (&#8220;KOL&#8221;) and members of its Scientific Steering Committee in the United States, Canada and Europe. This analysis revealed multiple efficacy signals for the high dose group when compared to the placebo group:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">At week 16, there was a statistically significant reduction of draining fistulas (&#8220;DF&#8221;) relative to baseline in the high dose IFX-1 group when compared to placebo (Figure 1 &#8211; relating to all patients with at least
        1DF at baseline).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="z4f9c49df35594ad9b14b4df484406811" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; font-size: 8pt; text-align: right;"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font>/7<br>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="ze30f47c0d8424f9e99e816be33df576a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100.00%;">
                  <div style="text-align: justify;">
                    <div style="font-weight: bold; text-align: left;"><img src="image00006.jpg"> </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div style="text-align: center;"><img src="image00010.jpg"></div>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; font-size: 8pt;">Figure 1: Draining Fistula (DF) reduction relative to baseline at week 16 (left: Mean, right: Median) in all patients with at least 1 draining fistula at baseline. For mean comparisons and the p-value
        of high dose versus placebo, an ANCOVA model adjusted for DF and Hurley stage at baseline was calculated. The p-value for the median comparison of high dose versus placebo was based on the Wilcoxon rank-sum test. Complete case analysis, no
        imputation of missing values.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">This reduction in DF was visible as early as 2 weeks after induction of high dose IFX-1 therapy and consistent over time with the strongest observed reductions seen at weeks 6, 8 and 16 (Figure 2). A temporary
        weakening of the strong reduction was observed between weeks 10 to 14 which could not be explained by pharmacokinetic or pharmacodynamic parameters. The strong relative reduction of draining fistulas observed in the SHINE trial was consistent with
        earlier findings in the open label Phase IIa study (manuscript under revision for publication).</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: center;"><img src="image00011.jpg">
        <div></div>
      </div>
      <div style="text-align: center;">&#160;<br>
      </div>
      <div style="text-align: justify; font-size: 8pt;">Figure 2: Draining Fistula (DF) reduction relative to baseline per visit (left: Mean, right: Median) until week 16 for placebo and the high dose group (IFX-1 1200mg q2w) in all patients with at least
        one DF at baseline. For mean comparisons of high dose versus placebo, an ANCOVA model adjusted for DF and Hurley stage at baseline was calculated. Complete case analysis, no imputation of missing values.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="z4f9c49df35594ad9b14b4df484406811" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; font-size: 8pt; text-align: right;"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font>/7<br>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="ze30f47c0d8424f9e99e816be33df576a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100.00%;">
                  <div style="text-align: justify;">
                    <div style="font-weight: bold; text-align: left;"><img src="image00006.jpg"> </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: center;">
        <div>
          <div style="text-align: justify;">As indicated in the initial press release from June 5, 2019, IFX-1 therapy reduced the AN count at week 16 relative to baseline with a trend to a dose dependent effect. Further analysis showed that high dose
            IFX-1 therapy reduced abscesses and inflammatory nodule counts over time (Figure 3):</div>
        </div>
        <div><br>
        </div>
        <img src="image00012.jpg">
        <div><br>
        </div>
      </div>
      <div style="text-align: justify; font-size: 8pt;">Figure 3: AN count per patient visit (left: Mean, right: Median) until week 16 for placebo and high dose group (IFX-1 1200mg q2w). Complete case analysis, no imputation of missing values.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">As a result of discussions with both, the Scientific Steering Committee, and leading KOLs, InflaRx conducted an additional post-hoc analysis utilizing the International Hidradenitis Suppurativa Severity Score System
        (&#8220;IHS-4&#8221;), which is scoring the patient according to all inflammatory lesions in contrast to the HiSCR. In this compounded score, each inflammatory nodule is counted with 1 point, each abscess with 2 points and each draining fistula with 4 points.
        Patients scoring with 0-4 are considered mild, with 5-10 moderate and with a score of 11 or higher as severe. Applying the IHS-4 score, there was a statistically significant relative change to baseline at the end of the treatment period on week 16
        (Figure 4) when comparing the high dose IFX-1 treated group to placebo group. A trend to a dose response across IFX-1 treated groups when compared to placebo could be detected.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="z4f9c49df35594ad9b14b4df484406811" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; font-size: 8pt; text-align: right;"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font>/7<br>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="ze30f47c0d8424f9e99e816be33df576a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100.00%;">
                  <div style="text-align: justify;">
                    <div style="font-weight: bold; text-align: left;"><img src="image00006.jpg"> </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: center;"><img src="image00013.jpg"></div>
      <div><br>
      </div>
      <div style="text-align: justify; font-size: 8pt;">Figure 4: IHS4 score reduction relative to baseline at week 16 (left: Mean, right: Median) for placebo and the high dose group (IFX-1 1200mg q2w). For mean comparisons and the p-value of high dose
        versus placebo, an ANCOVA model adjusted for IHS4 and Hurley stage at baseline was calculated. The p-value for the median comparison of high dose versus placebo is based on the Wilcoxon rank-sum test. Complete case analysis, no imputation of
        missing values.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">The relative change over time of the IHS-4 score showed similar patterns in the placebo and high dose group when compared to the relative change in DF with the strongest reductions at week 6, 8 and 16 together with a
        temporary weakening of the signal during week 10 to 14. Efficacy signals were also detected in the high dose group for the Hidradenitis Suppurativa Physician Global Assessment Score (&#8220;HS-PGA&#8221;), which scores patients&#8217; severity in six categories:
        clear, minimal, mild, moderate, severe and very severe according to the amount and quality of inflammatory lesions. IFX-1 treatment resulted in a more pronounced shift of severe and very severe patients into groups of lower severity when compared
        to the placebo group. This difference was most prominent on week 8 and week 16. Patients shifting to the category clear disease were only detected in IFX-1 treated groups but not in the placebo group at week 16.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Pharmacokinetic and pharmacodynamic (&#8220;PK/PD&#8221;) analysis demonstrated a dose dependent suppression of C5a and IFX-1 levels and suggested that the high dose group (1200mg q2w) offered a superior control over C5a levels
        when compared to the other dosing groups. IFX-1 treatment in all dose groups resulted in sustained CH50 levels, as sign of an intact activation of the membrane attack complex confirming earlier findings. The company is running additional population
        PK analysis and statistical models to estimate tissue PK, using all available data, to guide possible future dosing and to estimate tissue penetration of IFX-1 in HS.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">The detection rate of confirmed anti-drug antibodies (&#8220;ADA&#8221;) in the first 16 weeks of the SHINE trial was overall low (&lt;10% including pre-dose findings) for patients in both, the placebo group and the combined
        IFX-1 treated groups.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="z4f9c49df35594ad9b14b4df484406811" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; font-size: 8pt; text-align: right;"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font>/7<br>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="ze30f47c0d8424f9e99e816be33df576a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100.00%;">
                  <div style="text-align: justify;">
                    <div style="font-weight: bold; text-align: left;"><img src="image00006.jpg"> </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;">The company is continuing the open label extension part of the SHINE trial with the last patient dosing being expected for end of August 2019. Additional data will be analyzed as it becomes available.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;">Conference call details:</div>
      <div><br>
      </div>
      <div>Date: <font style="font-weight: bold;">Friday, 19 July 2019</font></div>
      <div>Time: <font style="font-weight: bold;">8 am EDT, 2 pm CEST</font></div>
      <div>From the US: 877-407-0789</div>
      <div>From outside the US: +1 201-689-8562</div>
      <div>Conference ID: 13692883</div>
      <div>To join the audio-only webcast, register here: <u>http://public.viavid.com/index.php?id=135498</u></div>
      <div>Please dial in 10 minutes before the call to register.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;">About IFX-1:<br>
        <br>
      </div>
      <div style="text-align: justify;">IFX-1 is a first-in-class monoclonal anti-human complement factor C5a antibody, which highly and effectively blocks the biological activity of C5a and demonstrates high selectivity towards its target in human blood.
        Thus, IFX-1 leaves the formation of the membrane attack complex (C5b-9) intact as an important defense mechanism, which is not the case for molecules blocking the cleavage of C5. IFX-1 has been demonstrated to control the inflammatory response
        driven tissue and organ damage by specifically blocking C5a as a key &#8220;amplifier&#8221; of this response in pre-clinical studies. IFX-1 is believed to be the first monoclonal anti-C5a antibody introduced into clinical development and has, to date,
        successfully completed three clinical Phase II studies. More than 150 people have been treated with IFX-1 in these completed clinical trials, and the antibody has been shown to be well tolerated. IFX-1 is currently being developed for various
        inflammatory indications, including Hidradenitis Suppurativa, ANCA-associated vasculitis and Pyoderma Gangraenosum.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">About InflaRx N.V.:</div>
      <div style="text-align: justify; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify;">InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement
        C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann
        Arbor, MI and New York, NY, USA. For further information please visit www.inflarx.com.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="z4f9c49df35594ad9b14b4df484406811" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; font-size: 8pt; text-align: right;"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font>/7<br>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" id="ze30f47c0d8424f9e99e816be33df576a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100.00%;">
                  <div style="text-align: justify;">
                    <div style="font-weight: bold; text-align: left;"><img src="image00006.jpg"> </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; color: #000000; font-weight: bold;">Contacts:</div>
      <div style="text-align: justify; color: #000000; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; color: #000000; font-weight: bold;">Investor Relations</div>
      <div style="text-align: justify; color: #000000; font-weight: bold;">InflaRx N.V.</div>
      <div style="text-align: justify; color: #000000;">Jordan Silverstein</div>
      <div style="text-align: justify; color: #000000;">Head of Corporate Development and Strategy</div>
      <div style="text-align: justify; color: #000000;">Jordan.silverstein[at]inflarx.de</div>
      <div style="text-align: justify; color: #000000;">+1 917-837-1709</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Media Relations</div>
      <div style="text-align: justify; font-weight: bold;">MC Services AG</div>
      <div style="text-align: justify;">Katja Arnold, Laurie Doyle, Andreas Jungfer</div>
      <div style="text-align: justify;">inflarx[at]mc-services.eu</div>
      <div style="text-align: justify;">+49 89-210 2280</div>
      <div><br>
      </div>
      <div>FORWARD-LOOKING STATEMENTS</div>
      <div style="text-align: justify;">This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221;
        &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; and similar expressions. Forward-looking statements appear in a number of places throughout this release
        and may include statements regarding our intentions, beliefs, projections, outlook, analyses and current expectations concerning, among other things, our ongoing and planned preclinical development and clinical trials, the timing of and our ability
        to make regulatory filings and obtain and maintain regulatory approvals for our product candidates, our intellectual property position, our ability to develop commercial functions, expectations regarding clinical trial data, our results of
        operations, cash needs, financial condition, liquidity, prospects, future transactions, growth and strategies, the industry in which we operate, the trends that may affect the industry or us and the risks uncertainties and other factors described
        under the heading &#8220;Risk Factors&#8221; in InflaRx&#8217;s periodic filings with the Securities and Exchange Commission. These statements speak only as of the date of this press release and involve known and unknown risks, uncertainties and other important
        factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these risks, uncertainties and
        other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <div id="DSPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; font-size: 8pt; text-align: right;"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font>/7<br>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  [ )X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WCXH>-HO!
M.AI<B$7%[<.8[>)C@$@9+-[#C\Q]:^;O$'Q(\5:X[?:=6GAB;_EC:GRD'M\O
M)_$FO?/C5X(O/&.CV;:4R?;K)V9(W;:)%8#(ST!^48S[UYGX#^#.LSZW;S^)
MH([33X7#O$9%=YL?P@*3@'N3VKGJ*;E9;'WG#]7*L+@OK%=Q]HKWOOY))^78
M]J^&&FR:5X#T>WN-QN&A\Z4L<MN<ESGW&['X5U%1M-#&=K21H1V+ 8I6EC6(
MR,Z",#)<G  ^M;I65CXBO6=>K*K+>3;^\?152TU.PO)#':7MM/(.JQRJQ_(&
MC5[K[#I5Y=?\\87D'U )IF1P7C;Q_+8WTEAHPCWQ';).PW8;N%'3CU-<I;>-
M?$IG0K>L^YL!6B3!]NE97ANU34_$EG#<MF.68&0L<9'4\_3-?0,(MFC$4(A,
M:  (F,+^%,1Q7Q&\3:AH+:?#8R(LLB,TI* YZ =?QK1^'6KZAK6DSW>I.K$3
M>6FU O  )Z?6O/\ XLW7G^*VB!R((4CQ]?F_]FKT;X<VOV7P?8 _>D#2G\2<
M?IB@9TM%-ED2)"\KJB#JS' %9_\ ;ND;]O\ :ECN]//7_&D!I5XK^TC\1]8\
M"0Z'%X=GBANKQI7E,D2R?(NT#K[M^E>SPRQS('AD21#T9&R*^/OVNM3^U_$B
MULE.4LK%%(]&=F8_H5IH:,G_ (:#^('_ $$+3_P#C_PJ_I/[1_C6TN%:^73;
M^'/S(\'EDCV*D8_(UZG^ROX8T]_AJ]_J%A:W,MY>R.CS0JY"*%0 9'3*M7._
MM:^%=!TO1-(U73;"ULM1ENC _P!GC$8E38220."00.?>@#V7X5?$/3?B)H+W
MM@C6]U P2ZM';+1,>A![J><'V/I7:U\F?L;F;_A,-="Y^S_8!O';=YB[?TW?
MK7UG2$%%9WB'6].\.Z/<:IK-TEK8VXS)*^3C)P  .22>PKAH?CAX G8K!K4D
MK 9(2RG8X_!* +_Q0\07NC#3TTVX,,LA=G(4'(&,=1[FE^%MU>ZG;ZAJ&HW$
MD\C.L2ESP HR<#H/O#I7)_%ZZ\[Q,D(/$$"J1[G)_D17<_#B$6'@F"63C?OG
M;Z9/] *8'EOCJZ^U^+M2D!RJR^6/^ _+_2M9HM9\6P0V6D1O_9=C&L2[FV*S
M #DYZD]?:N2D,E]J#$ M+/)T]6)KZ$T/3H=$T2"U3 6&/+L/XFZL?SH$?/D,
MESINH*Z,T5S;R>O*L#7M/Q!OC'X'N)/NO<*B ?[Q!/Z9KQR,'5-<4?Q75QC\
M6;_Z]>E?&2X$6DZ=9J<;Y2^/91C_ -FH \[\.Z#>:_=206'EAXT\QC(V!C('
M]:]7^'7AF[\/)>M?F(R3% OEMNP!G_&L7X+VN(=2NCW*1*?IDG^8KT6_G%K8
MW%PW2*-I#^ S0,\ \67/VWQ1J,HYW3LJ^X!P/T KV;4M2M_"GA>!YADPQ)#'
M&#@NP7I^E>+>'(#?^);")OF\RX7=[C//Z9KJ/B_J#3Z[#9 _N[:($C_:;D_I
MMH$8S3ZYXUU;RPS2L?F"9VQQ+Z^P_6G^*O"-UX<LX)[FY@E\U]@6,G(.,]QT
MKT/X4Z:EIX:6ZVCSKMRQ;OM!( _0G\:YCXQZ@)=4L[%&SY$9=P/[S=OR _.@
M";X,0,UYJ-P2=J1JG7@DG/\ [+7RS\<=3_M;XL>);@-N5+LVZGVC C_]EKZ\
M^%JIIW@^\OYN$+O*Q_V47_\ 77PTYGUWQ Q'-S?W7YL[_P")H12/K#X5_%#P
M'X5^&FAZ;=Z]$EU;6P::)8)682,2S+PN"<L17A7QQ^)#_$;Q)";&*6+2+,&.
MTB?[[EB-SL!W. ,=@![U%\8OA5?_  WN;-I+M;_3KL$1W*Q^7AQU1ER<''(Y
MYY]*]0_9/T[PAJJW,L^F(_BG3V$@DG<N#&3PZ*>%(/![C@YYH\P\SI/A/X"\
M0>#/A#J]]II%KXNU",74:21!RBH,I$5/\1&[Z%AZ5Y_\/_CYXJN/&ND6WB6^
MM6TF>X6&X_T=(]H;Y0VX#C!()^E?75? ?QNLM)L/BAKT6@W$<UF9RY$?W8Y&
MY= >^&ST^G:A CJ_CY\1;CX@^*(M#T R3:/:S>5;I$"3=S$[=^.X[*/3GO7O
MWP*^%T'@+0?M&H)'+K]Z@-R_40KU$2GT'<]S[ 5YO^R/X/TBZAO/%%Q(ESJE
MM,;>&$C_ (]OE!W^Y8' /8 _A]-T,&?/OC6Y^V>+-2D!R/.*#Z+\O]*]:U?_
M (D_P[DC^ZT=DL/_  (@+_,UC?\ "L[=KS[1+J4CDOO8&(#=SD]ZZSQ-HXUW
M27L6G,".RL6"[LX.<?RI"/'/AS9_;?%UD&&4B)F;_@(R/UQ7L7BVY^R>&=3F
M!P1 R@^Y&!^IK)\)>"X/#NH27:73SN\9C 9-N,D'/7VK9\2:2-;TB:P:=H%D
M*DNJY/!S_2@#QCX>6WVOQAIX(R$<RGVV@D?J!6S\8KKS=?MK<=(8 3]22?Y8
MKLO"G@B#P]J;7B7;SL8S&%9-H&2.>OM^M0>(O ,6MZO/?S:A)&TN,((P0H
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:&2*XFB:-U.#R%C!X(!'->ET44 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00010.jpg
<TEXT>
begin 644 image00010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #[ FX# 2(  A$! Q$!_\0
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M  .C_P#BJL?\)3H/_09T[_P(3_&@#9HK&_X2G0?^@SIW_@0G^-'_  E.@_\
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MP )XW>XJI4Y15VB8U(2=HL[2BL7^T]6_Z ,W_@5%_C1_:>K?] &;_P "HO\
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M_%K4K20)I5Y]E<JT5S$LT-[\K#>"V^W7@],#/KGM6Q\)O+_X1=_)\K;]I?\
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MZ$*^6:]+!? _4\K'_&O0];_9T_Y#6L_]>\?_ *$:]WKPC]G3_D-ZS_U[Q_\
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M_P#R)^G?]?Z_^BWKYVKTL+_#/*Q?\0^C?V<_^1)O/^O]_P#T!*]4KRO]G/\
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MI"@GF>4*822NYB<=?>@#SOPK_P C/I&.#]KB_P#0Q7TGMD_YZ?\ CM>8Z/\
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MXP;'H:=117.=04444 %>+V,5J?BBLXFT*#7(+UH9(EGM6GNT=G+.5!WKLCV
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M%% !1110 4444 %%%% !1110!R?Q8_Y)WK?_ %Q'_H2U\LU]2_%C_DG>M_\
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MS,WEL^_;M^8C[OW0!79UY1H.J:Y>^/=1T^*]DGB2\225VO(?+A1'DW1K#GS
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M(K?#S6P-W^I'52/XEKY=KZU\<Z3<:YX3U+3;(QBXN(PB&0D+G(/) /I7B?\
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M%)D>HHR/44 +129'J*,CU% "T4F1ZBC(]10 M%)D>HHR/44 +129'J*,CU%
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M-X3TB:6ZEO+6.\DN+G[4[7*+(1)L" KD<84;1CMGUK5M[1+:!(;<F*&,;41
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MMS[5T7ACP[JUOK$&I>(+VSN)[2Q_L^W6TB9%*EE+2-N)^9MB\#@8/7-=?10
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MO^%:>$_^@4?_  *F_P#BZ/\ A6GA/_H%'_P*F_\ BZ=H=W]W_!%>?9??_P
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M/NM@9&VO4=(TNSTFT^SZ?9VMI&S&1TMHA&A<_>; ]: +M%%% !1110 4444
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M:W&J7)G<6Q.V(>6D8"DCDX0$G Y/2I7\/Q-HVHZ<UW=21WL+PL\K!B@92O'
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M(=0 $RI5A@>SZE90:EI]S97:[[>XC:*0=.",'\:Q/"7A&T\/2W%YYTMUJUX
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DA<@?NU8@MCODXQ],^IK2HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00011.jpg
<TEXT>
begin 644 image00011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #L G<# 2(  A$! Q$!_\0
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M +Z/^%&9/[B?]]'_  I]% #,R?W$_P"^C_A1F3^XG_?1_P *?10 S,G]Q/\
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M<>F?2A REXB_Y%_4_P#KUE_] -36+M]AM_W;?ZM>X]/K4/B+_D7]3_Z]9?\
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M?XT^B@!F]O\ GFWYC_&C>W_/-OS'^-/HH 9O;_GFWYC_ !I59B>48>^13J*
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MZ%<]!G^."KVGV%IIT'D6%M#;0YW;(D"C/K@52N/^1KT__KRN?_0X* -+S?\
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MA_\ OFCS?]A_^^:DJIJVH6VE:=<7U]((K:!2[L?Y#U)Z8H6N@-VU9F>*M?\
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M#+)+,P:669R[O@!1DGT  J&X_P"1KT__ *\KG_T."@#3\V/_ )Z)^='FQ_\
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M/^$=TV7_ $=2>+R=?^6A]47MZGFK'B:ZGU[5#X9TN5HTVA]3N4.##$>D8/\
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MC/\ LL.#^%7O#FL0:[H\%_;@KO&)(V^]$XX9#[@Y%:2]Y<R,X>Z^1FAYL?\
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MLD=M'.[F1V1F6#@#RRHYQST'4D6[![':>(=:M]#LHY[GDRRK#&NX*&<YZLQ
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MM[.+7]*C:35=+.]$C&3-$2 \9 Y((Y]B,U'8^*=>OK.">W\(W2^8@;]_=QQ
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M-=VNM&P5<,@(;$B9 W#D^O'>I92.P\&F%O">D&V*- ;6,H41T!&T<[7)8?\
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MD>(JHD:/S%C)[,4Y].1SGBK>MZ*NIV%];)<SP&]58Y6\QG'EY&X*I;"DKD9
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M*AE./0@@_P#UP:BN/^1KT_\ Z\KG_P!&04FAZ3+87%[=WERMS>7A3S'CB\M
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M[XBSC"D.I(4AMH(?&0V1D5OZ?H-I8ZYJ&J0&037F-T88B-3@98(.-S8&6ZG
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M8F29IVP;#<#ET;&"F" (SSD#'!;'5:-IXTS3X[;SY[EQ\SS3-N>1CU)[#Z#
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MW@  8 4  <=AR<DY-,\,Z!;:);,T<-LM_<*AO9K>/RUGE5<%]N<#/)_&MF@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00012.jpg
<TEXT>
begin 644 image00012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #7 F\# 2(  A$! Q$!_\0
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MQ^M #Z*9^]_V/UH_>_['ZT /HIG[W_8_6C][_L?K0 ^BF?O?]C]:/WO^Q^M
M#Z*9^]_V/UH_>_['ZT /HIG[W_8_6C][_L?K0 ^BF?O?]C]:/WO^Q^M #Z*9
M^]_V/UH_>_['ZT /HH&<<XS[44 %%%% $<\,5Q&8YXDEC/)5U# _@:6.&*-4
M6.-%6,80*H 7Z>E/HH R_%7_ "*^L?\ 7G-_Z :THO\ 5)_NBLWQ5_R*^L?]
M><W_ * :THO]4G^Z* '45#<W4%J$-Q*D>]MB;C@LWH/4\=*3[7$!G]Y]S?\
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M6L;;LF7YB"<2N.G3OQ_7O0 _,O\ =3_OH_X49E_NI_WT?\*;]FCW9S+G?O\
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M;XIN/NIIEDO^U+),P_+:*Z:B@#FET+6)CF\\27('=;6!(Q^9W&G?\(?ITO\
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M 'R*/(B_YYI_WR* )**C\F+_ )YI_P!\BCR8O^>:?]\B@"2BH_)B_P">:?\
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M+=!E@..YQ7>US&LC7;#7I+_2K!-5MI[>.'[.UWY!@968E@""I#;AD]?E'4=
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M(KH],U*RU2W$^G7<%U"?XXG##]*G\P_\\W_3_&N=U+PEI5Y<&[M[>?3K\_\
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M#74>8?\ GF_Z?XU+5G9E)IJZ)**13D9P1[&EI#"JZ65K'>/=QVT*W4BA'F5
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M9+5FRPB/SK+&/LN.>\NY#].U=]::?;6C7)@B"FXE,\N23N<@#//3A1^56L4
M16_FI:Q?:2'F"#S"BX!;') ^M+YH_N2?]\U)10!'YH_N2?\ ?-'FC^Y)_P!\
MU)10!'YH_N2?]\T>:/[DG_?-244 1^:/[DG_ 'S4E%% !1110 5F^)+JWLM#
MN[B]-R+>--S"V+"0\C 4KSDG XQUZBM*B@#%\&F<^&;(W5S]IG*L6?S#)C+$
MA2YY;:,+N[XS4&CO>-XDU<W=O;Q2>1;@+'.9!C,O.2B\^V*Z&LBQ_P"1HU7_
M *][;^<M &GF7^XG_?9_PHS+_<3_ +[/^%244 1YE_N)_P!]G_"C,O\ <3_O
ML_X5)10!'F7^XG_?9_PHS+_<3_OL_P"%244 ,S+_ '$_[[_^M3Z** *>J7%W
M;6N^PLC>S;@/*$JQ\>N3Q61_:^O_ /0LM_X'Q5T=% '$>(]3U>1=&BDL;VP>
MXOFA:&TN8FDE002MPQ( ^90>O:LN'7]6T87\>KWT1U1(+5 KQ--&9O)D=PJJ
M5QG823D#@GT%>DLBLREE4E3E21G!Z9'YU%/9VUP")[>&7)#'>@;)'0\^E+H,
MX2/QU=S:)J&K)!:K'9VD4XLR2996>W67(;( 4;L=#G8QR*BOM>ULW^@^?/96
M#O>7$1=W!AFC%N75F1)&P<_PE^V?:O0/L=KYJR_9H?,5/+5_+&0O]T'T]J9_
M9MC]G%O]CMO(&2(_*7:,]>,8IO782.)TSQQ>W_V2?[-;0Q/-9P/:-N,S^?&K
M%T.0-J[_ .Z<A&Y%>@5$;: W"3F"(SHNU9"@W*/0'KBI: ,S7+W4;..(Z7I3
M:D[,0ZBX2+8/7+=:R/[<\3?]"@__ (,8:ZJBJ4DEL2XMO?\ (X;Q?JVMQ^#Y
M;YU;0+F"YBRGF1S&5"Z@C=R #DYXSQVZU/KVI7$?BB&+1KR6>X@A>XO+7<IB
M6+RF\M<8SO9]I&#G ;MBNKN[.VO(PEY;PSH#D+*@< ^O-,73;%;A)Q9VPG0
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MNOM?#VEVT31BR@D4RR3#S4#[6=BS8R.!D]*T&MH&D+M!$7+!RQ09)'0_4=J
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MH_\ B: -BBL*YU35[>VEGDT:+9$A=L7@S@#/]VMFUF%Q;13*"%D0. >HR,T
M24444 %!( ))P!U-%8GC&UN+S0S%;1&?$\,DL (S+$LBLZ<\'*@\'KT[T ;2
MD,H*D$'D$5DV/_(T:K_U[VW\Y:@\&64]CI=PDT)MHY;N::"W./W,3.2JX' ]
M<#IG%5;6PUY=?U&7[=9JCPP*LAL6PV#)D#][VR/S% '445D?9M<_Z"EA_P"
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M%+LC/V!OWB[5.[_6^I(_"@#H**R/LVN?]!2P_P# !O\ X[1]FUS_ *"EA_X
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M],\9KC-?BU:VO+BUNE_M:UUD36MN8X5$ECO7H>F8MH!8DY##OD  '<T$ C!
M(]ZS?#MA=:=I,,%_>M>W0&9)2NU<X'"KV48X')]236EG'6@ K/T_6M/U#4+^
MQM+E)+NQ<)<18(9"1D<'J.>HXZCM4.K>=JFGM;Z+JL=I=,(YEGC592J%L@[3
MP0VTC/UQ7)>']#.N>)9=;U6&[L[ZPN-H$1"P23*H21T;[SQLJH,,  <XRPR
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M+&P88D7&\*V P7)X//0>#/"EAH$3W$6GVUK?7!9Y!$ WE[L$HK8!QD9QTSG
M P O@_PG:Z#;0O*D%QJ*!D^U" 1OLS\J\$C*KM7/<**Z:@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00013.jpg
<TEXT>
begin 644 image00013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #S G # 2(  A$! Q$!_\0
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M'+3\S_A7*_'/_4Z-_O3?R2O)\GUH ^CK?Q9HMS"LMO>^;$W1XXG93^(6I?\
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MSX]?\DXN_P#KO#_Z&*J$>:2B3.7+%R-7_A97@W_H8M/_ ._E6[#QQX;U#?\
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M_?B3_P")H_X272O^?B3_ +\2?_$UL45SG28S>)])526N7  R28)./_':R_\
MA9'@[_H8;#_ONNFU#_CPN?\ KDW\C7QFI^4?2NFA056]V<N(Q#HVLMSZKMOB
M!X5NIUAM=;M9YF^['&2S'Z #-7_^$FTK_GXD_P"_$G_Q-?/'P?/_ !<;1_\
M>D_]%/7U!45Z2I2LF7AZSK1YFC.L=9L;Z?R;65WDQG!B=>/J0!6C116)N4M;
MN9[+1K^ZLX#<W,%O)+%"/^6CJI(7\2,5P7@KQ3=WWB#3[1?$EEXBCO+9Y[E+
M:V6,V#* 1G:20"25VO\ -G'/!KL_%EEJ>H^'KVTT._33[^:-DCN'C+[<@CL0
M0??MUP:S=%T'6K?5;>\U778KF.)&!@MK(6XE=@!ND.]MV.W3DT('L;FH:E#8
MW.GP2K(SWLY@CVC@,$9\GVPA_2L'0/&4>K:A:V\FEWUE#?(\MA<3%"ERJ=2
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M_A1F3^ZGYG_"N ]$<WW3]*^(I?\ 6O\ [Q_G7VTQDVGA.GJ?\*^))?\ 6O\
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M_(W:YW_TZ?\ ]&-5KX=#/CWP_P!O]-C_ )U5\9?\C?KG_7_/_P"C&JW\.?\
MD?O#_P#U^Q_SKUW\'R/%7Q_,^N_+_P"FC_G1Y?\ TT?\Z?17D'M#/+_Z:/\
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MI!(!]001VIWB[_D!OG_GO!_Z.2IM'TB/39+N;SYKFZNW#S3S;=S[5"J,*
M!V'KZU#XNYT-\_\ /:#_ -')0!K>8G]Y?SH\Q/[R_G2[%_NC\J-B_P!T?E0
MGF)_>7\Z/,3^\OYTNQ?[H_*C8O\ ='Y4 )YB?WE_.CS$_O+^=+L7^Z/RHV+_
M '1^5 %>\GECMV:TCBGFXPCR^6#^.#_*N%>X\_QK=W.DV/DWMA:S)M96C&H7
M#JI"ER #&FT#<>Y..G/H6Q?[H_*C:/0?E0!YKX+EN-"AUZVU!+FWOKW4 +>6
MY(?[3</;(S%=I8 ;E8_W0.,\&K/PO>[AQ!<V\>/L,,EU=M:M!+]J).^-V8DR
M$=<]L^XKOGMX7DCD>*-GCR48J"5R,'![<4_:IZ@?E0 GF)_>7\Z/,3^\OYTN
MQ?[H_*C8O]T?E0 UI$VGYEZ>M?$<G^M?_>/\Z^W61=I^4=/2OB*3_6/_ +Q_
MG7;@^IP8W[/S.H^%9Q\1- S_ ,_'_LK5]:^8G]Y?SKY*^%?/Q%T#/_/Q_P"R
MM7UML7^Z/RJ<7\2+P7P/U$\Q/[R_G1YB?WE_.EV+_='Y4;%_NC\JY#L/,_V@
MV4^ !A@?],BZ'_>KYKKZ4_:#4#X?C  _TR+M_O5\UUZ6%_AGEXO^(?0O[-[*
MOA74\D#_ $X]3_TS2O6O,3^\OYUY+^S>H/A74\@'_3CU'_3-*]:V+_=7\JXJ
M_P#$9W8?^&@\Q/[R_G1YB?WE_.C8O]U?RHV+_=7\JR-CYE^-!!^(VID$$;8?
M_12UQ2?ZQ?J*[7XT#'Q&U/''RP_^BEKBH_\ 6+]17M4OX<?0\*M_$EZGV<LB
M;1\Z]/6E\Q/[Z_G2*B[1\J]/2EV+_=7\J\4]T=1110 4444 %<[XLTF6[N=.
MU&QU6+2]0LR\<4L\(EB=9  R,I9<YVK@A@>/<UT5>:_&JS6>TTN=S #"[;3=
MV\KV\9RC;V=%;RV&W 8C&&89% T=AX4T8Z+83QRWAO;JYN)+FXGV! TC'G"C
MA0, 8YZ<DFJ.MZW?M-<V.G^%;W5(ERDKS/%! X(Y ,C98<_W<>]/\ Q$://=
MO?6-[)?74EVS6#[X$+8^5&[XQR>,DDX%<SXZN9;G4KS3=.EO)EN7CM[FVE"F
M R;0ZK&S'Y6*@94@QMG!*DDT,2.PT#6KG4)7M[[1+_3)T3?^^V21.,X^61&(
M/T.#[5M.2%)4 MC@$XS7.> +>WMM!*VSRG=,[21R6PM_)<]4$0X0#T&0<DY.
M<UMW5A;7,RS20Q_:44K'/L4R1Y'\+$<4,$<A:>-KB[U(Z7;6EE/?&X$"2Q71
M:W/[HR-\^S.5  ( ZL.>N.E\,ZLNNZ':ZBL30^<&#1D[MC*Q5AGOR#S64_@V
MWDU)=3DU&_;5T*[+W]V'555UV[0FPC$CYRI//7@8W-'TZWTG3;>QLPP@A7:N
MXY)[DD]R223]: *=T0/%NGY('^@W/7_KI!6MYB?WE_.LFZ /BW3\@'_0;G_T
M9!6OL7^Z/RH \L^.3!H=&VD'YI>A]DKRBO5_CF (M&P /FE_DE>44 >__"]U
M'@;306 .).__ $T:NJ\Q/[R_G7*_"]5/@;3<@?\ +3M_TT:NKV+_ '1^5 ">
M8G]Y?SH\Q/[R_G2[%_NC\J-B_P!T?E0!\;^,?^1OUS_K_G_]&-5KX<G'CWP_
MG_G]C_G57QEQXOUS_K_G_P#1C5:^'7_(^^'\_P#/[%_.O7?P?(\5?'\SZ]\Q
M/[R_G1YB?WE_.EV+_='Y4;%_NC\J\@]H3S$_O+^=>>?'IE/PYN\,#^_AZ'_;
M%>B;%_NC\J\[^/2@?#B[P /W\/;_ &Q6E+XT95OX<O0^8Z]N_9I8*WB'<0.(
M.I_ZZ5XC7MW[- !?Q#D \0=?^VE>AB/X;/.PW\5'N/F)_>7\Z/,3^\OYTNQ?
M[H_*C8O]T?E7EGK">8G]Y?SKYQ_:)(/CBUP0?] 3I_OO7T?L7^Z/RKYP_:)
M'CBUP /] 3_T-ZZ,+_$.7%_PSRUONGZ5]E>$74>$]%^9?^/*#O\ ],UKXU;[
MI^E?97A%%/A/1<J/^/&#M_TS6M\9LC#!?$S6\Q/[R_G1YB?WE_.C8O\ =7\J
M-B_W5_*N ]$KZ@Z&PN?F7_5-W]C7QJGW%^E?9>H(OV"Y^5?]4W;V-?&B?<7Z
M5Z&"VD>;C]X_,[/X0$#XC:.3P-TG_HIZ^G_,3^\OYU\O_"  _$;1\C/S2?\
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MXCVK0\7<:&_&?WT'_HY* -FBH][_ //)OS'^-'F/_P \F_,?XT 245'YC_\
M/)OS'^-'F/\ \\F_,?XT 245'YC_ //)OS'^-'F/_P \F_,?XT 245'YC_\
M/)OS'^-'F/\ \\F_,?XT 245'YC_ //)OS'^-'F/_P \F_,?XT 245'YC_\
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M(!(& 2*6J(UC33=S6HU"T-S""98A,NZ, 9.X9R, YYH N11)#&$B140=%48
MK)\7?\@-_P#KO!_Z.2M"POK34(/.L+J"ZASMWPR!USZ9%9_B[_D!O_UW@_\
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MLD;@,KH<A@>A![BD,R[C_D;=/_Z\;G_T9!6O61<?\C;I_P#UXW/_ *,@K7H
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MHM]6C@^S_9AY"VIMT=R7V]0S9&6SD@=#1SN]OT0>S5KZ_>S9_L3Q=_T.$/\
MX*D_^+H_L3Q=_P!#A#_X*4_^+K2N;/4CKB/"<:?N7<HEB QW^4PEO_'Q^%<?
MKFGS2^)=1 LYCJ3:C82:?.(6*I;KY9EPX&%'$^X$\[N^11SO^D@]FO/[V;W]
MB>+O^APA_P#!2G_Q=']B>+O^APA_\%*?_%US?BB!]2U'5I+>SNGN;BWM%T>7
M[*Z^6ZRMYA!*CRR#M+$XRN.HJ'7+?^T+OQ'<:+8W%J8;<VAACMWCDO?WRM-+
MT&<*&5.=QW,1P11SOR^Y![->?WLZK^Q/%W_0X0_^"E/_ (NC^Q/%W_0X0_\
M@J3_ .+KE=3@M8K'78[;2&DL=1NE@TU6LW$5NQ@59)]NW**""> ,L..3FO3-
M+M88M,M(U)G"0HHEE7YWP -S9[GJ:.=_TD'(O/[V<[_8GB[_ *'"'_P5)_\
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M[Y% $E%1^3%_SS3_ +Y%'DQ?\\T_[Y% $E%1^3%_SS3_ +Y%'DQ?\\T_[Y%
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M +X- $E%1^<O]V3_ +X-'G+_ '9/^^#0!)14?G+_ '9/^^#1YR_W9/\ O@T
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M*JOIUC)?+>R6=LUX@PLYB4R*/9L9[FK5, HHHH **** "BBB@ HHHH ****
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M$HXDP/DFQ*1@_*S\9[5J>+/&DMOK=G=Z->+=Z1:2K#=+:;)5:1F(9)3NW(<
M;#C:6/S'%=1X*33KNQDU:ST:UTVZO)'%QY2H3(R.R[MZC#@D$@]\YH WK.#[
M+:0P"267RD">9*VYVP,98]R>YJ:BB@ HHJKJFH6FE6,M[J$Z06L0R\C]!DX'
MXDD#% &1X[U(Z;X?DVPVLK73K: WAQ;H9/ES*1_!V/KD#O7,>';F7Q#XT:=Y
MGTV2VC6.]LX<LEU)"[;'CF& \0\PY'#9"A@!UQE\:7UOJVHK>Q+K&G:BK26T
M3R1_9Y8P^P+ XSO)7:#&WS%V/ 7)KUJRM+>QM8[>RMXK:WC&$BB0(J_0#@4
M3T444 %%%% !1110 4444 %%%% !7.>-]#N=<T^V2U>V=K:83FTNXP]O=8!&
MR3C('.01G! .#C%='10!R7PVTZ2RT$&^L#97HED0PL-WV>/>2L*/U>-<_*>G
MH!T'6T44 %%%#' )P3CL* ,GQ7JKZ)H%U?QQH[1;1^\)")N8+O<C)"+G<Q]
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M/S(C(C9 &2<'H17>TB@+]T <YXH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *X?0? ,6E^*)-66[:-8RR6T%NH16B;)*S
M#G>06PIX*JJC/7/<44 %%%% !1110!0UO2X-9TY[.Z:5$+)(KPOL='1@RLI[
M$, ?PKE/ _@VZT#6+JXN)8VB_>JKI/)(]UOEWB28-\JLHRHVY^\QSSBNZHH
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C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
